Clinical Trial Update: CB1R in Synthetic Psychoactive Cannabinoids [NA]

View source ↗

Summary

A Yale University-sponsored clinical trial investigating CB1 receptor involvement in synthetic psychoactive cannabinoids for drug dependence is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug Dependence

Snippet

Sponsor: Yale University | Conditions: Drug Dependence | NA | Status: ACTIVE_NOT_RECRUITING